Revium Rx. (RVRC) Form 10-Q Quarterly Reports
Revium Rx. (RVRC) is a publicly traded company on the OTC, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: RVRC
CIK: 1839140
Exchange: OTC
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Ziv Haft Certified Public Accountants (Isr.)
Auditor SinceSince 12/31/2024 12:00:00 AM
Lead Engagement PartnerOmer Margalit
Audit LocationTel Aviv, Israel
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 10-Q | 2026-08-13 | 2026-06-30 | QUARTERLY REPORT | 0001213900-26-089070 | View SEC Doc Filr Page |
| 8-K | 2026-06-22 | 2026-06-16 | CURRENT REPORT | 0001213900-26-070415 | View SEC Doc Filr Page |
| 8-K | 2026-06-01 | 2026-05-27 | CURRENT REPORT | 0001213900-26-063235 | View SEC Doc Filr Page |
| 10-Q | 2026-05-14 | 2026-03-31 | QUARTERLY REPORT | 0001213900-26-056600 | View SEC Doc Filr Page |
| 8-K | 2026-04-20 | 2026-04-14 | CURRENT REPORT | 0001213900-26-045633 | View SEC Doc Filr Page |
| 10-K | 2026-03-31 | 2025-12-31 | ANNUAL REPORT | 0001213900-26-037573 | View SEC Doc Filr Page |
| EFFECT | 2026-01-30 | — | EFFECT Filing | 9999999995-26-000363 | View SEC Doc Filr Page |
| S-1/A | 2026-01-28 | — | AMENDMENT NO. 5 TO FORM S-1 | 0001213900-26-008804 | View SEC Doc Filr Page |
| S-1/A | 2026-01-16 | — | AMENDMENT NO. 4 TO FORM S-1 | 0001213900-26-005242 | View SEC Doc Filr Page |
| S-1/A | 2025-12-12 | — | AMENDMENT NO. 3 TO FORM S-1 | 0001213900-25-121070 | View SEC Doc Filr Page |
| S-1/A | 2025-10-03 | — | AMENDMENT NO. 2 TO FORM S-1 | 0001213900-25-096094 | View SEC Doc Filr Page |
| S-1/A | 2025-08-13 | — | AMENDMENT NO. 1 TO FORM S-1 | 0001213900-25-075747 | View SEC Doc Filr Page |
| S-1 | 2025-02-14 | — | REGISTRATION STATEMENT | 0001213900-25-013823 | View SEC Doc Filr Page |